CAR T cells based on fully human T cell receptor–mimetic antibodies exhibit potent antitumor activity in vivo
2025; American Association for the Advancement of Science; Volume: 17; Issue: 791 Linguagem: Inglês
10.1126/scitranslmed.ado9371
ISSN1946-6242
AutoresRobert Salzler, David J. DiLillo, Kei Saotome, Kevin Bray, Katja Mohrs, Haun Hwang, Kamil J. Cygan, Darshit Shah, Anna Rye-Weller, Kunal Kundu, Ashok Badithe, Xiaoqin Zhang, Elena Garnova, Marcela Torres, Ankur Dhanik, Robert Babb, Frank J. Delfino, Courtney Thwaites, Drew Dudgeon, Michael J. Moore, T. Craig Meagher, Corinne E. Decker, Tomasz B. Owczarek, Joseph Gleason, Xiaoran Yang, David Suh, Wen‐Yi Lee, Richard S. Welsh, Douglas MacDonald, Johanna K. Hansen, Chunguang Guo, Jessica R. Kirshner, Gavin Thurston, Tammy Huang, Matthew C. Franklin, George D. Yancopoulos, John C. Lin, Lynn E. Macdonald, Andrew Murphy, Gang Chen, Olav Olsen, William C. Olson,
Tópico(s)Immunotherapy and Immune Responses
Referência(s)